Navigation Links
Zimmer and Tutogen Announce Agreement for International Distribution of Biological Products
Date:9/4/2007

WARSAW, Ind. and ALACHUA, Fla., Sept. 4 /PRNewswire-FirstCall/ -- Zimmer Holdings, Inc. (NYSE: ZMH; SWX: ZMH), a leader in the orthopaedics industry, and Tutogen Medical, Inc., a leading manufacturer of sterile biological implant products made from human (allograft) and animal (xenograft) tissue, today announced the expansion of Tutogen's partnership with Zimmer Dental Inc., a wholly owned subsidiary of Zimmer Holdings, Inc., into Europe, the Middle East and Asia. Zimmer Dental currently distributes Tutogen grafts in the United States, Canada and Latin America, under the brand name Puros(R). This enhanced distribution agreement includes both human and bovine tissues -- bone and soft tissue grafts -- and provides the dentist with a complete product package for the regenerative procedure.

According to David Dvorak, President and Chief Executive Officer of Zimmer Holdings, Inc., Zimmer Dental's parent company, "We look forward to leveraging the success and experience that we have achieved in the U.S. market with Puros dental products from Tutogen. This is an outstanding international market opportunity for Zimmer Dental as it enables us to continue to define ourselves as an innovator in advanced materials and in state-of-the-art oral rehabilitation technologies."

Guy Mayer, President and Chief Executive Officer of Tutogen Medical, commented, "Our dental products have demonstrated superior clinical results in the U.S. market. We look forward to extending our relationship with Zimmer Dental in globalizing this fast growing product portfolio. Working together we have a demonstrated track record of success in developing the North American market. We believe that joint experience provides a strong foundation to bui
'/>"/>

SOURCE Zimmer Holdings, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related biology technology :

1. Speaker announces business members of IT Task Force
2. Doyle announces technology tax credits for Berbee
3. Doyle announces new energy, global warming policies
4. Doyle, WARF announce partnership to lure stem cell companies
5. Doyle announces $80M renewable energy strategy
6. GE announces first installation of Discovery VCT
7. UWM announces winners of RGI awards
8. Third Wave announces two senior management appointments
9. Mirus announces new method for making antibodies
10. Merge announces sofware updates, upcoming acquisition
11. Small Tree announces ethernet solution for Apple Xserv G5

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)...stCall/--NeurogesX,Inc.(Nasdaq: NGSX ),abiopharmac...gnovelpainmanagementtherapies,announcedtodaythatAn...cheduledtopresentatthe21stAnnualPiperJaffrayHealth...kPalaceHotelinNewYork,NewYork. ,, Mr.DiTonnoand...abletorespondtoquestionsduringthepresentationsandt...
(Date:11/24/2009)...atientswithadvanced-stage,orrecurrentendometrialca...l/-AEternaZentarisInc.(NASDAQ: AEZS ;TSX:AEZ)(the"...endocrinetherapyandoncology,todayannouncedpositive...icpeptideconjugate,AEZS-108(formerlyAN-152),inpati...rsonalizedhealthcareapproach,thestudyselectedpatie...
(Date:11/24/2009)...FirstCall/--GenomicHealth,Inc.(Nasdaq: GHDX )today...airman,willpresentatthe21stAnnualPiperJaffrayHealt...09at10:00a.m.ET. ,, Toaccesstheliveandsubsequen...orRelationssectionofGenomicHealth,swebsiteat http:...bsiteatleast15minutespriortothebeginningoftheprese...
(Date:11/24/2009)...-CellTherapeutics,Inc.(CTI)(NasdaqandMTA:CTIC)mana...CareConference.TheconferencewillbeheldDecember1-2,...onTuesday,December1at11:00a.m.EasternTimeinHolmes1...lbeavailableat www.celltherapeutics.com ,anditwill...ayHealthCareConference,NewYorkPalaceHotel,Holmes1(...
Breaking Biology Technology:NeurogesX to Present at Piper Jaffray Health Care Conference 2NeurogesX to Present at Piper Jaffray Health Care Conference 3AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 2AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 3AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 4Genomic Health to Present at Piper Jaffray Health Care Conference 2
... Eiger BioPharmaceuticals, Inc.,a start-up biotec...nounced,that it has raised $7.1 million in a Serie...o Ventures. The two firms were instrumental in the...eam and are represented on the board of,directors ...gelman,respectively. The funding will advance the...
...-FirstCall/ - Angiotech Pharmaceuticals, Inc. (NAS...ceutical and medical device company, today announc...d conference call. The call will take place at 10:..., , , Dial information for the earnings call o...ows:, North America (toll-free): (800) 291-9234...
... An investor group in Trinity,Biotech plc (Nasdaq:...er of,diagnostic products, has petitioned the Offi...ilitate compliance with key company law provisions...ders and prospective shareholders. , The petit...directors,Peter Coyne of Allied Irish Bank, and Dr...
Other Biology Technology:Eiger BioPharmaceuticals Raises $7.1 Million 'A' Round 2
(Date:11/23/2009)...tudy by University of Alabama at Birmingham (UAB) ...o-existing medical conditions (co-morbidity) do no...rican-Americans compared to Caucasians who also ha.... 23 in Cancer , a journal of the American Cancer...BMI and co-morbidity are independent predictors of...
(Date:11/23/2009)...fornia biomedical engineer and cardiologist Tzung ...linicians distinguish cardiac emergencies requirin...le with drugs and lifestyle change. , Angiograms...ies feeding the heart, offer an inside view of the..., often revealing deposits of a dangerous fatty su...
(Date:11/23/2009)... , , , , , , , ..., Dr Andrew Marshall, from the Environment Depa...scovery of Kinyongia magomberae and his wider wo...r more information. , , , , ... , , , , , , A new species of ch...
Breaking Biology News(10 mins):Racial disparity in colon cancer survival not easily explained, UAB researchers say 2Stable plaque or heart attack plaque? USC researcher builds new sensor to tell which is which 2New chameleon species discovered in East Africa 2New chameleon species discovered in East Africa 3Medicares Missing Link 3A Care Coordination and Family Caregiving by Dan Tobin M D CEO of Care Support of America 56877 1Medicares Missing Link 3A Care Coordination and Family Caregiving by Dan Tobin M D CEO of Care Support of America 56877 2Medicares Missing Link 3A Care Coordination and Family Caregiving by Dan Tobin M D CEO of Care Support of America 56877 3Medicares Missing Link 3A Care Coordination and Family Caregiving by Dan Tobin M D CEO of Care Support of America 56877 4Pro Dex Inc Announces Fiscal 2009 Fourth Quarter Financial Results Conference Call and Webcast 56874 1Pro Dex Inc Announces Fiscal 2009 Fourth Quarter Financial Results Conference Call and Webcast 56874 2The 231 Stay Healthy Secret Whole Body Cleanse 28TM 29 from Enzymatic Therapy 56870 1The 231 Stay Healthy Secret Whole Body Cleanse 28TM 29 from Enzymatic Therapy 56870 2
...ersity of Delaware have uncovered a hidden weapon ...e United States uses to silently and efficiently b...hragmites australis, or common reed, believed to h...n acid so toxic that the substance literally disin...ighboring plants, thus toppling the competition. ,...
...ome analysis of a tiny green alga has uncovered hu...carbon dioxide capture and generation of biomass. ...are those that encode the structure and function o...ynthetic apparatus, the chloroplast, which is resp...The genome also provides a glimpse back through ti...
...chnology infrastructure for researching and develo...ave the industry hundreds of millions of dollars a...red by the National Institute of Standards and Tec...or NIST, the studys authors found that over the la...s shifted from small-molecule chemicals to large-m...
Other Biology News:UD plant biologists uncover top wetland plant's hidden weapon 2UD plant biologists uncover top wetland plant's hidden weapon 3Green alga genome project catalogs carbon capture machinery 2Green alga genome project catalogs carbon capture machinery 3Biopharmaceutical infrastructure key to lower drug development costs 2
Anti-4-hydroxy-2-hexenal Monoclonal Antibody, Unconjugated from Cosmo Bio Co., Ltd.
Anti-Human VEGFR-2 / KDR Antibody, Unconjugated from Cell Sciences
Rabbit Anti-Human Tankyrase 2 (TNKL (TNKS2) Polyclonal Antibody, Unconjugated from Lifespan Biosciences
...olved in translation initiation. PHAS-II is highes...E, the mRNA cap-binding protein, and inhibit trans...horylation in the appropriate site(s) promotes dis...F-4E to bind to eIF-4G (p220), thereby increasing ...
Biology Products: